MY181172A - Composite preparation comprising active ingredient-containing film coating layer - Google Patents
Composite preparation comprising active ingredient-containing film coating layerInfo
- Publication number
- MY181172A MY181172A MYPI2016002270A MYPI2016002270A MY181172A MY 181172 A MY181172 A MY 181172A MY PI2016002270 A MYPI2016002270 A MY PI2016002270A MY PI2016002270 A MYPI2016002270 A MY PI2016002270A MY 181172 A MY181172 A MY 181172A
- Authority
- MY
- Malaysia
- Prior art keywords
- film coating
- coating layer
- composite preparation
- active ingredient
- containing film
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
.Provided are a composite preparation and a method for producing same, the composite preparation comprising a core containing a first active ingredient; and a film coating layer containing a 5-a-reductase inhibitor, wherein the film coating layer is formed by coating with a film coating solution in which the film coating materials are dissolved in a mixed solvent of water and about 30-80 wt% of an organic solvent with respect to a total weight of the mixed solvent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20140081223 | 2014-06-30 | ||
KR1020150093777A KR20160002411A (en) | 2014-06-30 | 2015-06-30 | COMPOSITE FORMULATION COMPRISING 5-α-REDUCTASE INHIBITOR-CONTAINING FILM COATING LAYER AND A PROCESS FOR THE PREPARATION THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
MY181172A true MY181172A (en) | 2020-12-21 |
Family
ID=55019633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2016002270A MY181172A (en) | 2014-06-30 | 2015-06-30 | Composite preparation comprising active ingredient-containing film coating layer |
Country Status (2)
Country | Link |
---|---|
MY (1) | MY181172A (en) |
WO (1) | WO2016003180A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11771691B2 (en) | 2018-05-19 | 2023-10-03 | Zim Laboratories Limited | Pharmaceutical composition of Tamsulosin and Dutasteride |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005016981A1 (en) * | 2005-04-13 | 2006-10-19 | Bayer Healthcare Ag | Combination therapy for benign prostatic hyperplasia |
BR112012015282A2 (en) * | 2009-12-22 | 2016-03-15 | Abbott Healthcare Private Ltd | controlled release pharmaceutical composition |
WO2012127495A2 (en) * | 2011-02-28 | 2012-09-27 | Titan Laboratories Pvt. Ltd. | A pharmaceutical composition and process for preparation thereof |
KR101310710B1 (en) * | 2011-03-23 | 2013-09-27 | 한미약품 주식회사 | Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor |
KR20140013436A (en) * | 2012-07-24 | 2014-02-05 | 한미약품 주식회사 | Composite formulation for oral administration comprising metformin and rosuvastatin |
-
2015
- 2015-06-30 WO PCT/KR2015/006742 patent/WO2016003180A1/en active Application Filing
- 2015-06-30 MY MYPI2016002270A patent/MY181172A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2016003180A1 (en) | 2016-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016502536A1 (en) | Composite preparation comprising 5-a-reductase inhibitor-containing film coating layer, and method for producing the composite preparation | |
CL2017000288A1 (en) | Encapsulation of biologically active hydrophobic compounds | |
MX2017008425A (en) | Fungicidal compositions. | |
CL2015002164A1 (en) | Combined formulation of two antiviral compounds. | |
CO2018005639A2 (en) | Trisubstituted and similar silylphenoxyheterocycles | |
EP3369792A4 (en) | Antifouling film, antifouling film forming composition, antifouling film laminate, and production method for antifouling film laminate | |
CL2013003576A1 (en) | Pharmaceutical composition comprising nilotinib; dosage form comprising nilotinib; method to prepare nilotinib; method for preparing the dosage form; and use of an organic acid to increase the bioavailability of nilotinib and to suppress the effect of the food associated with the pharmaceutical composition. | |
CL2013002504A1 (en) | Solid coated pharmaceutical preparation comprising at least one active ingredient and because the coating has a thickness of 0.1 to 100 nm, preferably 0.3 to 50 nm and more preferably 0.5 to 35 nm; and its method of preparation | |
CO6660482A2 (en) | N - [(het)] arilethyl) pyrazole] (uncle) carboximides and their hetero substituted analogs | |
UY35047A (en) | PROCEDURE FOR PREPARATION OF A SLOW RELEASE FERTILIZER | |
EP3225685A4 (en) | Cell preservative solution, use of same, and method for producing cell preservative solution | |
AR102563A1 (en) | DENSIFIED COMPOSITION FOR THE TREATMENT OF A UNDERGROUND FORMATION | |
EP3241875A4 (en) | Resin composition for hard coating, and hard-coating film comprising cured form of same as coating layer | |
EP3138834A4 (en) | Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient | |
MX2017006524A (en) | Color-changing adhesive composition. | |
EP3315137A4 (en) | Composition for outer layer of solid preparation, and easy-to-take solid preparation including said composition for outer layer | |
MX2016006292A (en) | Composite formulation comprising tadalafil and amlodipine. | |
EP3281980A4 (en) | Resin composition and multilayer structure using same, and method of improving long-run stability | |
EP3205924A4 (en) | Electrochemical luminescent cell and composition for forming luminescent layer of electrochemical luminescent cell | |
PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
EP3241824A4 (en) | Trifluoroacethydrazide compound as well as preparation method therefor and application thereof in preparing medicament | |
EP3124442A4 (en) | Method for stopping swimming or crawling of adhesion-stage larvae | |
MX366651B (en) | Crystal form alpha of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same. | |
EP3153156A4 (en) | Composition based on a stabilized solution of active ingredients | |
MY181172A (en) | Composite preparation comprising active ingredient-containing film coating layer |